Menu
Currency
GWAS Study

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.

Ising M, Lucae S, Binder EB et al.

19736353 PubMed ID
GWAS Study Type
1898 Participants
86 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

IM
Ising M
LS
Lucae S
BE
Binder EB
BT
Bettecken T
UM
Uhr M
RS
Ripke S
KM
Kohli MA
HJ
Hennings JM
HS
Horstmann S
KS
Kloiber S
MA
Menke A
BB
Bondy B
RR
Rupprecht R
DK
Domschke K
BB
Baune BT
AV
Arolt V
RA
Rush AJ
HF
Holsboer F
MB
Müller-Myhsok B
Chapter II

Abstract

Summary of the research findings

Context: The efficacy of antidepressant drug treatment in depression is unsatisfactory; 1 in 3 patients does not fully recover even after several treatment trials. Genetic factors and clinical characteristics contribute to the failure of a favorable treatment outcome.

700 European ancestry cases

Chapter III

Study Statistics

Key metrics and study information

1898
Total Participants
GWAS
Study Type
Yes
Replicated
832 European ancestry cases, 366 European ancestry controls
Replication Participants
European
Ancestry
Germany
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.